Strategies for Targeting SARS CoV-2: Small Molecule Inhibitors—The Current Status

Strategies for Targeting SARS CoV-2: Small Molecule Inhibitors—The Current Status

Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2) induced Coronavirus Disease - 19 (COVID-19) cases have been increasing at an alarming rate (7.4 million positive cases as on June 11 2020), causing high mortality (4,17,956 deaths as on June 11 2020) and economic loss (a 3.2% shrink in gl...

Full description

Bibliographic Details
Main Authors: Narasimha M. Beeraka, Surya P. Sadhu, SubbaRao V. Madhunapantula, Rajeswara Rao Pragada, Andrey A. Svistunov, Vladimir N. Nikolenko, Liudmila M. Mikhaleva, Gjumrakch Aliev
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-09-01
Series:Frontiers in Immunology
Subjects:
SARS-CoV
SARS-CoV-2
COVID-19
natural Nrf-2 modulators
NSMIs
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2020.552925/full

Internet

https://www.frontiersin.org/article/10.3389/fimmu.2020.552925/full

Similar Items